A pH/MMP-9 smart dual-responsive liposome GBE@LP co-delivers and controls the release of GB1107/BMS1166/Enzalutamide for liver cancer immunotherapy
Liver cancer is one of the malignant tumors with high morbidity and mortality worldwide and lacks effective clinical treatments. CD8+ T cell-based immunotherapy is the most promising option for the treatment of liver cancer, but its application is severely limited by low infiltration and functional...
Saved in:
| Main Authors: | Shijia Lu, Chenxiao Zhang, Huiru Wu, Junjie Wang, Jinglong Wang, Limei Zhao, Tianyang Ren, Guofei Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Materials Today Bio |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425003618 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Tumor-associated tertiary lymphoid structures response during immunotherapy
by: Ileana Soto Mauldin, et al.
Published: (2025-04-01) -
Design and verification of a DMA controller based on the ICB bus
by: Su Xing, et al.
Published: (2024-01-01) -
The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
by: Wenhua Xia, et al.
Published: (2025-01-01) -
A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan‐Cancer
by: Weiquan Hu, et al.
Published: (2025-03-01) -
Visual Outcomes and Patient Satisfaction of Enhanced Monofocal Intraocular Lens in Phacovitrectomy for Idiopathic Epiretinal Membrane
by: Ji Youn Choi, et al.
Published: (2024-09-01)